Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

320 projects found matching your search criteria :

  1. Design and synthesis of acylpeptide hydrolase inhibitors as potential inducers of apoptosis in tumor cells

    Call: PRELUDIUM 5 , Panel: ST5

    Principal investigator: Maciej Walczak

    Politechnika Wrocławska, Wydział Chemiczny

  2. RNA chaperone activity of HIV-2 Gag and nuclocapsid proteins: implications for the design of the new retroviral inhibito...

    Call: SONATA 1 , Panel: NZ1

    Principal investigator: dr Katarzyna Pachulska-Wieczorek

    Instytut Chemii Bioorganicznej PAN

  3. Design and synthesis of selective and irreversible inhibitors of HAT protease.

    Call: PRELUDIUM 5 , Panel: ST5

    Principal investigator: Marcin Skoreński

    Politechnika Wrocławska, Wydział Chemiczny

  4. Phosphonic inhibitors of human neutrophil elastase in cancer therapy

    Call: SONATA 5 , Panel: NZ4

    Principal investigator: dr Łukasz Winiarski

    Politechnika Wrocławska, Wydział Chemiczny

  5. Determination of the structural elements responsible for the narrow substrate specificity of staphylococcal proteases Sp...

    Call: PRELUDIUM 1 , Panel: NZ1

    Principal investigator: Michał Zdżalik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  6. Inhibition of activity tryptophan hydroxylase-1 - the new conception in the treatment of mineral and bone disorders in c...

    Call: OPUS 5 , Panel: NZ7

    Principal investigator: prof. Krystyna Pawlak

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  7. New methods for mRNA 5' end labeling and examples of their application in studies on RNA metabolism and searching for in...

    Call: OPUS 5 , Panel: ST5

    Principal investigator: dr hab. Jacek Jemielity

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego

  8. Inhibitory neurotransmitter GABA in the aging of nervous system

    Call: OPUS 5 , Panel: NZ3

    Principal investigator: dr Monika Liguz-Lęcznar

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

  9. Assessment of mechanisms of tumour necrosis factor alpha (TNF-alpha) inhibitors' action in rheumatoid arthritis female p...

    Call: PRELUDIUM 5 , Panel: NZ5

    Principal investigator: Anna Szeremeta

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  10. Morita-Baylis-Hillman adducts as substrates in the synthesis of biologically active organophosphorus compounds

    Call: OPUS 5 , Panel: ST5

    Principal investigator: dr hab. Artur Mucha

    Politechnika Wrocławska, Wydział Chemiczny

  11. Synthesis and studies of reaction products of oxirane derivatives with the -NH-(C=)-Br functionality of heteroaromatic c...

    Call: PRELUDIUM 1 , Panel: NZ4

    Principal investigator: dr Marzena Baran

    Uniwersytet Jagielloński-Collegium Medicum, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

  12. Extracellular proteolytic activity of human epithelium - role in the modulation of signal transduction.

    Call: SYMFONIA 1 , Panel: NZ1

    Principal investigator: prof. Jan Potempa

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  13. The role of neutral endopeptidase (NEP) and its inhibitor, sialorphin, in colon cancer cells biology.

    Call: OPUS 4 , Panel: NZ3

    Principal investigator: prof. Martyna Kandefer-Szerszeń

    Uniwersytet Marii Curie-Skłodowskiej, Wydział Biologii i Biotechnologii

  14. Design, chemical synthesis and enzymatic evaluation of peptidic substrates and inhibitors of cathepsin C

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: dr Monika Łęgowska

    Uniwersytet Gdański, Wydział Chemii

  15. Synthesis and preliminary studies on biological activity of glycosyltransferases natural substrates analogues, derivativ...

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: Roman Komor

    Politechnika Śląska, Wydział Chemiczny

  16. One-pot synthesis of O-2-isocepham and N-2-isocepham derivatives bearing retroamide/thioretroamide or phosphono/thiophos...

    Call: PRELUDIUM 4 , Panel: NZ7

    Principal investigator: Marta Schielmann

    Politechnika Gdańska, Wydział Chemiczny

  17. Theoretical model of SH2-dependent STAT1 dimerization as a novel tool to identify specific compounds of functional inhib...

    Call: PRELUDIUM 4 , Panel: NZ2

    Principal investigator: Małgorzata Szeląg

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  18. Kinases of emerging relevance in cancer - structural characterization.

    Call: SONATA BIS 2 , Panel: NZ1

    Principal investigator: dr Grzegorz Dubin

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  19. Synthesis and pharmacological properties of mono- di- and triheterocyclic azole derivatives as a hybrid receptor and PDE...

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: prof. Maciej Pawłowski

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  20. DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Śliwiński

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  21. Search of novel multifunctional ligands targeting neurodegereneration processes.

    Call: OPUS 4 , Panel: NZ7

    Principal investigator: prof. Barbara Malawska

    Uniwersytet Jagielloński-Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  22. New chemical and biological properties of topoizomeraze I inhibitors alkylating DNA oligomers

    Call: OPUS 4 , Panel: ST4

    Principal investigator: prof. Lech Kozerski

    Instytut Chemii Organicznej PAN

  23. Synthesis and analysis of potential furin inhibitors in the development of the new therapeutic strategies against viral ...

    Call: PRELUDIUM 4 , Panel: ST5

    Principal investigator: Monika Lewandowska-Goch

    Uniwersytet Gdański, Wydział Chemii

  24. In vitro/in vivo characteristics of hydrophilic matrix containing phosphodiesterase-5 inhibitors.

    Call: SONATA 4 , Panel: NZ7

    Principal investigator: dr Anna Krupa

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  25. Cardioprotective effect of inhibitors of matrix metalloproteinase-2 (MMP-2) and inhibitors of posttanslational modificat...

    Call: HARMONIA 3 , Panel: NZ3

    Principal investigator: prof. Mieczysław Woźniak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej

  26. Effect of deimination of essential arginine residues on the function of protease inhibitors and other components of inna...

    Call: OPUS 3 , Panel: NZ6

    Principal investigator: dr Tomasz Kantyka

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  27. Impact of combined therapy of non-steroidal anti-inflammatory drugs and selective serotonin reuptake inhibitors on oxida...

    Call: OPUS 3 , Panel: NZ5

    Principal investigator: dr hab. Piotr Gałecki

    Uniwersytet Medyczny w Łodzi, Wydział Wojskowo-Lekarski, Klinika Psychiatrii Dorosłych

  28. Structure - activity relationship studies of new flavonoids derivatives as the inhibitors of the bacterial tyrosyl-tRNA ...

    Call: PRELUDIUM 3 , Panel: NZ7

    Principal investigator: dr Mirosława Skupińska

    Instytut Chemii Bioorganicznej PAN

  29. Stilbene and stilbazole derivatives as potential cyclooxygenase-2 (COX-2) inhibitors with probable antitumor and chemopr...

    Call: PRELUDIUM 1 , Panel: NZ4

    Principal investigator: Miłosz Regulski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

  30. Stimulation of endogenous neurogenesis as a novel therapeutic strategy in neonatal hypoxic-ischemic brain injury.

    Call: OPUS 3 , Panel: NZ3

    Principal investigator: dr Małgorzata Nałęcz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  31. The role of corticotropin releasing factor (CRF) in low and high anxiety rats, and teh iteraction between of the CRF sys...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr Anna Skórzewska

    Instytut Psychiatrii i Neurologii

  32. Diaminophosphonates as specific inhibitors of Neisseria meningitidis aminopeptidase N - synthesis and biological activit...

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: Ewelina Węglarz-Tomczak

    Politechnika Wrocławska, Wydział Chemiczny

  33. Evaluation of pharmacological activity of new, nonselective gamma-aminobutyric acid (GABA) transport inhibitors in some ...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr hab. Kinga Sałat

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  34. Organometallic inhibitors of tubulin polymerisation. Synthesis, anticancer activities and tubulin affinities.

    Call: OPUS 3 , Panel: ST5

    Principal investigator: dr hab. Damian Plażuk

    Uniwersytet Łódzki, Wydział Chemii

  35. Modifications of aglycones of leucomycins via Michael addition and Huisgen dipolar cycloaddition as a new routes of synt...

    Call: SONATA BIS 1 , Panel: ST5

    Principal investigator: dr hab. Piotr Przybylski

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Chemii

  36. Identification of amino acid residues located in positions P7 and P8 of model inhibitor of proprotein convertases that d...

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: Izabela Małuch

    Uniwersytet Gdański, Wydział Chemii

  37. Synthesis of mononucleotide N2,N2,7-trimethylguanosine cap analogues as translation inhibitors in Ascaris suum

    Call: PRELUDIUM 3 , Panel: ST5

    Principal investigator: dr Karolina Piecyk

    Uniwersytet Warszawski, Wydział Chemii

  38. The influence of metabolic pathway inhibitors on the development and quality of bovine embryos produced in vitro.

    Call: OPUS 3 , Panel: NZ9

    Principal investigator: dr hab. Dorota Cieślak

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Medycyny Weterynaryjnej i Nauk o Zwierzętach

  39. Pattern-Specific Inhibitors (PSI) - introduction and basic characteristics of a new class of inhibitors that block recog...

    Call: OPUS 3 , Panel: NZ6

    Principal investigator: dr Krzysztof Guzik

    Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

  40. Peptide splicing - the mechanism and its application for designing compounds with potential use in medicinal practice

    Call: OPUS 1 , Panel: ST5

    Principal investigator: prof. Krzysztof Rolka

    Uniwersytet Gdański, Wydział Chemii

  41. Research into the understanding of a defense mechanism of wheat (Triticum aestivum) in response to feeding Oulema spp. -...

    Call: OPUS 2 , Panel: NZ9

    Principal investigator: dr hab. Aleksandra Obrępalska-Stęplowska

    Instytut Ochrony Roślin - Państwowy Instytut Badawczy

  42. Solution NMR investigations of human cystatin C - structure, dynamics and protein-ligand interactions.

    Call: PRELUDIUM 2 , Panel: ST4

    Principal investigator: Martyna Maszota-Zieleniak

    Uniwersytet Gdański, Wydział Chemii

  43. Hydrogen exchange mass spectrometry (HXMS) for studying human serum amyloid A fibril formation.

    Call: PRELUDIUM 2 , Panel: NZ5

    Principal investigator: Marta Sosnowska

    Uniwersytet Gdański, Wydział Chemii

  44. Novel urease inhibitors as means to control ureolytic microbial pathogens

    Call: OPUS 2 , Panel: NZ6

    Principal investigator: dr Agnieszka Grabowiecka

    POLITECHNIKA WROCŁAWSKA

  45. Design, synthesis and biological evaluation of Steroid Sulfatase Inhibitors based on organophosphorus compounds.

    Call: SONATA 2 , Panel: NZ7

    Principal investigator: dr Sebastian Demkowicz

    POLITECHNIKA GDAŃSKA

  46. Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Artur Świerczek

    Uniwersytet Jagielloński, Collegium Medicum

  47. Inhibitory Functional Networks in Addiction Development within Social Context - a Missing Piece of Puzzle

    Call: OPUS 26 , Panel: NZ4

    Principal investigator: dr Marzena Stefaniuk

    Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polskiej Akademii Nauk

  48. Flozins as potential inhibitors of aortic stenosis progression in patients with concomitant type 2 diabetes: impact on v...

    Call: OPUS 26 , Panel: NZ5

    Principal investigator: dr hab. Joanna Natorska

    Uniwersytet Jagielloński

  49. Modulation of the N-glycosylation as a tool to improve the CAR-T immunotherapy efficacy

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Agnieszka Graczyk-Jarzynka

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  50. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Magdalena Wujak

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy